Drawing for ENVISIONONE

USPTO serial 98476408

ENVISIONONE

Reviewed by CopyMark Law Group

Reg. 8024979Status 700Registered
Filing date
Status date
Registration date
Nov 11, 2025
Examiner
GREEN, ASHLEY ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ENVISIONONE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Zachary A. Aria

Zachary A. Aria Blank Rome LLPOne Logan Square8th FloorPhiladelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
042Web site hosting services for the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Software as a service (SAAS) services, namely, hosting software for use by others for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Rental of software for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Platform as a service (PAAS) featuring computer software platforms for improving the efficiency in which companies bring products to market in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations; Design, development and implementation of software and software platforms for the life science, pharmaceutical and bio-pharmaceutical industries and academic research organisations; Software development for others in the life science, pharmaceutical and bio-pharmaceutical industries, and academic research organisations in the field of software configuration management; Providing a web hosting platform for the life science, pharmaceutical and biopharmaceutical industries and academic research organisations; Installation, maintenance, repair and updating of computer software and computer software platforms for the life science, pharmaceutical and bio-pharmaceutical industries and academic research organisations; Design, development and implementation of software for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software as a service (SAAS) services, namely, hosting software for global use by others for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software development for others in the field of software configuration management for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Design, development and implementation of software platforms that incorporate integrated and configurable software modules for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Platform as a service (PAAS) featuring computer software platforms incorporating integrated and configurable software modules for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Software development for others in the field of software platform configuration management for disclosing and disseminating scientific and medical data and information, managing evidence and tracking of scientific activity and grant requests; Technical support services, namely, technical advice related to the repair of computer software; Technical support services, namely, technical advice related to the maintenance of computer software; Consultancy services relating to software as a service (SAAS) services and the selection of software applications; Advisory, consultancy and information services relating to all the aforesaid servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 11, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 22, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 22, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 22, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 19, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 28, 2025IUAFUSE AMENDMENT FILED—
Apr 28, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Mar 11, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 14, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 14, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 8, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 18, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 18, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 18, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 20, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2024DOCKASSIGNED TO EXAMINER—
Sep 2, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 30, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance